A Study of PER-001 in Participants With Open-Angle Glaucoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This clinical study has two phases: Phase 1 and Phase 2a. Phase 1 is an open-label, single ascending dose (SAD), while Phase 2a is a randomized, single-masked (participant) with a sham control.
Epistemonikos ID: 472d8c4b14fc2e847d4c2f4205b9936197a894e6
First added on: Feb 19, 2024